- cafead   Feb 01, 2023 at 11:12: AM
via With GSK’s consumer healthcare spinoff now in the rearview mirror, the company is operating as the lean, innovative medicines-focused drugmaker CEO Emma Walmsley envisioned years ago (PDF).
And 2022’s financial performance shows the company’s promise as it seeks to grow sales by at least 5% annually through 2026.
article source
And 2022’s financial performance shows the company’s promise as it seeks to grow sales by at least 5% annually through 2026.
article source